Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy.
- DOI
- 10.1007/s00210-026-05479-3
- Published
- 2026 Aug
- Container
- Naunyn-Schmiedeberg's archives of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00210-026-05479-3,
title = {Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy.},
author = {Pawar A and Balme V and Pandhare R and Deshmukh V and Bhagat B and Belhekar S and Andhale V},
year = {2026},
journal = {Naunyn-Schmiedeberg's archives of pharmacology},
doi = {10.1007/s00210-026-05479-3},
url = {https://doi.org/10.1007/s00210-026-05479-3}
}RIS
TY - JOUR TI - Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy. AU - Pawar A AU - Balme V AU - Pandhare R AU - Deshmukh V AU - Bhagat B AU - Belhekar S AU - Andhale V PY - 2026 JO - Naunyn-Schmiedeberg's archives of pharmacology DO - 10.1007/s00210-026-05479-3 UR - https://doi.org/10.1007/s00210-026-05479-3 ER -
APA
A, P., V, B., R, P., V, D., B, B., S, B., & V, A. (2026). Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05479-3
Source records
- pubmed · retrieved 2026-09-27T10:27:08.519Z